SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Clene Reports Third-Quarter 2026 Financial Results and Operating Highlights

Clene said it submitted a New Drug Application to the FDA in October; the supplied body is truncated and does not provide further financial results.

CLNN

Related stories